Financial Reports
Related Searches:
Filter by:
January 15, 2008
Genentech
4Q Revenues: $3 billion (+9%)
4Q Earnings: $632 million (+6%)
YTD Revenues: $11.7 billion (+26%)
YTD Earnings: $2.8 billion (+31%)
Comments: U.S. product sales were up 19% to $8.5 billion for the year and $2.2 billion in the…
Read More »
December 21, 2007
BASi (Bioanalytical Systems)
4Q Revenues: $10.4 million (-3%)
4Q Loss: $203,000 (net loss of $736,000 in 4Q06)
FY07 Revenues: $45.2 million (+5%)
FY07 Earnings: $926,000 (net loss of $2.7 million in FY06)
Comments: Sales declined in 4Q…
Read More »
November 13, 2007
Catalent Pharma Solutions
1Q Revenues: $438 million (+10%)
1Q Loss: $11.3 million ($1.1 million in 1Q06 earnings)
Comments: Oral Technologies net revenue grew 9% to $235 million, while Sterile Technologies was up 26% to $71 million, fueled b…
Read More »
November 8, 2007
Hospira
3Q Revenues: $838 million (+30%)
3Q Earnings: $59 million (+6%)
YTD Revenues: $2.5 billion (+26%)
YTD Earnings: $61 million (-68%)
Comments: Integration of Mayne Pharma helped drive revenue growth, while restructuring costs dro…
Read More »
November 1, 2007
AstraZeneca
3Q Revenues: $7.2 billion (+10%, +6% at Constant Exchange Rates)
3Q Earnings: $1.4 billion (-15%)
YTD Revenues: $21.4 billion (+11%, +7% CER)
YTD Earnings: $4.4 billion (-6%)
Comments: In a deliberately obfuscatory earnings…
Read More »
November 1, 2007
Millennium Pharmaceuticals
3Q Revenues: $122 million (+18%)
3Q Loss: $1.7 million (loss of $13.7 million in 3Q06)
YTD Revenues: $346 million (flat)
YTD Loss: $26.2 million (loss of $52.2 million in YTD06)
Comments: U.S. net sales of Ve…
Read More »
October 31, 2007
Kendle International
3Q Revenues: $142 million (+47%)
3Q Earnings: $3.7 million (-5%)
YTD Revenues: $414 million (+62%)
YTD Earnings: $12.3 million (-6%)
Comments: Net service revenues grew 33% in 3Q07 to $100 million, and 49% YTD to $…
Read More »
October 25, 2007
Bristol-Myers Squibb
3Q Revenues: $5.1 billion (+22%)
3Q Earnings: $858 million (+154%)
YTD Revenues: $14.5 billion (+5%)
YTD Earnings: $2.3 billion (+35%)
Comments: Earnings for 3Q07 were boosted by $247 million from the sell-off of t…
Read More »
October 25, 2007
Covance
3Q Revenues: $415 mlllion (+16%)
3Q Earnings: $45 million (+17%)
YTD Revenues: $1.2 billion (+14%)
YTD Earnings: $125 million (+17%)
Comments: Early development results were up 19% to $200 million, while late-stage services ros…
Read More »
October 25, 2007
Amgen
3Q Revenues: $3.6 billion (flat)
3Q Earnings: $201 million (-81%)
YTD Revenues: $11.0 billion (+6%)
YTD Earnings: $2.3 billion (+10%)
Comments: Overall U.S. sales diminished 2% as Medicare reimbursement for Aranesp was lowered, w…
Read More »
October 24, 2007
Genzyme Corp.
3Q Revenues: $960 million (+19%)
3Q Earnings: $159 million (up from $16 million in 3Q06)
YTD Revenues: $2.8 billion (+19%)
YTD Earnings: $401 million (+60%)
Comments: Myzozyme sales rose 162% to $54 million in 3Q07, and t…
Read More »
October 24, 2007
GlaxoSmithKline
3Q Revenues: $11.1 billion (+5% in USD, -3% in local currency)
3Q Earnings: $2.7 billion (+2% in USD, -6% in local currency)
YTD Revenues: $33.3 billion (+6% in USD, -3% in local currency)
YTD Earnings: $8.4 billion (+8% i…
Read More »
October 23, 2007
Biogen Idec
3Q Revenues: $789 million (+12%)
3Q Earnings: $119 million (-24%)
YTD Revenues: $2.3 billion (+15%)
YTD Earnings: $437 million (+301%)
Comments: Avonex sales leveled off, up 2% to $455 million, while BI's share of Rituxan r…
Read More »
October 22, 2007
Merck
3Q Revenues: $6.1 billion (+12%)
3Q Earnings: $1.5 billion (+62%)
YTD Revenues: $18.0 billion (+8%)
YTD Earnings: $4.9 billion (+24%)
Comments: Singulair sales rose 17% to $1 billion. Diabetes treatment Januvia, launched in Octob…
Read More »
October 22, 2007
Schering-Plough
3Q Revenues: $2.8 billion (+9%)
3Q Earnings: $750 million (+142%)
YTD Revenues: $9.0 billion (+13%)
YTD Earnings: $1.9 billion (+97%)
Comments: Revenues do not reflect sales of Vytorin and Zetia, which are accounted as…
Read More »
